-
02:39:36 PM

HLTH Stock News

08/03/23 4:22 PM
Nasdaq : HLTH
covid-19
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
Cue Health, a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to develop a Flu A/B, RSV, and COVID-19...
RHEA-AI
neutral
06/06/23 3:49 PM
Nasdaq : HLTH
covid-19
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
Cue Health, a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and Drug Administration for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use. This sets a new standard as the first FDA De Novo authorization for a home use COVID-19 test and the...
RHEA-AI
neutral
05/31/23 4:01 PM
Nasdaq : HLTH
conferences
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
Cue Health, a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44 th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 4:00 p.m. Pacific Time at the Waldorf Astoria Monarch Beach Resort& Club. A live audio webcast and replay of the presentation may be accessed for 180 days on the“ Investor...
RHEA-AI
neutral
05/09/23 9:15 AM
Nasdaq : HLTH
clinical trial
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
Cue Health, a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration for full clearance of the Cue RSV Molecular Test for at-home and point-of-care use. There are currently no respiratory syncytial virus tests on the market for home use. It is the most common cause of bronchiolitis and...
RHEA-AI
neutral